Skip to content

A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01628614
Enrollment
4812
Registered
2012-06-27
Start date
2010-11-30
Completion date
2011-07-31
Last updated
2012-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Open-Angle, Ocular Hypertension

Brief summary

This is an observational study and will evaluate IOP reduction in newly diagnosed patients with POAG or OHT. All care (including treatment and diagnostic procedures) provided is at the discretion of the participating physicians according to their clinical judgment and the local standard of medical care.

Interventions

OTHERStandard of Care

Patients with POAG or OHT. All care (including treatment and diagnostic procedures) provided is at the discretion of the participating physicians according to their clinical judgment and the local standard of medical care.

Sponsors

Allergan
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Newly diagnosed with primary open angle glaucoma or ocular hypertension

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Patients With a Reduction in Intraocular Pressure (IOP) ≥ 5mmHg From BaselineBaseline, 14 WeeksPercentage of patients with a reduction in IOP≥5 mmHg from baseline. IOP is a measurement of the fluid pressure inside the eye. The minimum reduction of 5 mmHg was evaluated in the eye with the highest pressure at the baseline visit.

Secondary

MeasureTime frameDescription
Percentage of Patients With an IOP Reduction ≥10% From BaselineBaseline, 14 WeeksPercentage of patients with an IOP reduction ≥10% from baseline. IOP is a measurement of the fluid pressure inside the eye. The minimum reduction of 10% was evaluated in the eye with the highest pressure at the baseline visit.
Percentage of Patients With an IOP Reduction ≥20% From BaselineBaseline, 14 WeeksPercentage of patients with an IOP reduction ≥20% from baseline. IOP is a measurement of the fluid pressure inside the eye. The minimum reduction of 20% was evaluated in the eye with the highest pressure at the baseline visit.

Countries

Spain

Participant flow

Participants by arm

ArmCount
POAG or OHT
Patients with POAG or OHT. All care (including treatment and diagnostic procedures) provided is at the discretion of the participating physicians according to their clinical judgment and the local standard of medical care.
4,812
Total4,812

Baseline characteristics

CharacteristicPOAG or OHT
Age Continuous
Evaluable (N=2647 patients)
64.72 Years
STANDARD_DEVIATION 12.03
Age Continuous
Missing (N=2165 patients)
NA Years
Sex/Gender, Customized
Female
1642 Participants
Sex/Gender, Customized
Male
1389 Participants
Sex/Gender, Customized
Missing
1781 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
180 / 3,037
serious
Total, serious adverse events
0 / 3,037

Outcome results

Primary

Percentage of Patients With a Reduction in Intraocular Pressure (IOP) ≥ 5mmHg From Baseline

Percentage of patients with a reduction in IOP≥5 mmHg from baseline. IOP is a measurement of the fluid pressure inside the eye. The minimum reduction of 5 mmHg was evaluated in the eye with the highest pressure at the baseline visit.

Time frame: Baseline, 14 Weeks

Population: Evaluable Patients: all patients who met the study entry criteria

ArmMeasureValue (NUMBER)
POAG or OHTPercentage of Patients With a Reduction in Intraocular Pressure (IOP) ≥ 5mmHg From Baseline75.9 Millimeters of Mercury (mmHg)
Secondary

Percentage of Patients With an IOP Reduction ≥10% From Baseline

Percentage of patients with an IOP reduction ≥10% from baseline. IOP is a measurement of the fluid pressure inside the eye. The minimum reduction of 10% was evaluated in the eye with the highest pressure at the baseline visit.

Time frame: Baseline, 14 Weeks

Population: Evaluable Patients: all patients who met the study entry criteria

ArmMeasureValue (NUMBER)
POAG or OHTPercentage of Patients With an IOP Reduction ≥10% From Baseline91.0 Percentage of Patients
Secondary

Percentage of Patients With an IOP Reduction ≥20% From Baseline

Percentage of patients with an IOP reduction ≥20% from baseline. IOP is a measurement of the fluid pressure inside the eye. The minimum reduction of 20% was evaluated in the eye with the highest pressure at the baseline visit.

Time frame: Baseline, 14 Weeks

Population: Evaluable Patients: all patients who met the study entry criteria

ArmMeasureValue (NUMBER)
POAG or OHTPercentage of Patients With an IOP Reduction ≥20% From Baseline70.8 Percentage of Patients

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026